Most common adverse reactions (≥20%) for TAFINLAR are hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, and palmar-plantar erythrodysesthesia syndrome.
from FDA,2013.05
Dabrafenib is a drug used to treat melanoma, and its safety and side effects hav···【more】
Release date:2025-01-14Recommended:122